| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |